Well i took some, a little too much,my breast has gotten smaller since than now i barely have any breast .i weigh 138 5'6'' ,ive had taken herbal pills such as fenugreek and saw palmetto for few months now seems like nothing is working even massages.search online is herbal pills really work for breast enlargement im confuse some say it doesn't some say it does.i have very low self esteem because of my greed when i was younger,well now im soo desperate that i might choose to have silicone implants .Now i know that only 18 yr olds can take herbal pills etc..

please help,appreciate it!

TUESDAY, July 22 (HealthDay News) -- There's just no getting around the fact that mammograms are uncomfortable, but a new study suggests that applying a topical analgesic before the test could significantly ease the discomfort associated with the test.

And a test that's less painful may encourage more women to get screened, the researchers suggest.

I have fibrocystic breasts and have had two biopsy surgeries, thankfully both are benign.

Well, my 22 year old daughter had her SECOND BREAST LUMP removed 6 weeks ago and she is doing great. Her first one was removed 2 years ago and thank goodness both of her breast lumps were benign.

THURSDAY, June 26 (HealthDay News) -- Researchers have devised a new breast-imaging technology that appears to be as accurate as MRI scans but several times cheaper.

The technique, called molecular breast imaging (MBI), is still in the early stages of development, the scientists added.

THURSDAY, June 26 (HealthDay News) -- Women with metastatic breast cancer who developed an immune response to an investigational vaccine lived twice as long as those who didn't have an immune response, new research shows.

"If you were an immune responder, you had double the survival of a non-responder," said study author Dr. Susan Domchek, an associate professor of medicine at the University of Pennsylvania.

A gene that greatly increases a woman's risk of breast cancer also causes a particularly deadly form of prostate cancer, say Canadian researchers who studied 301 prostate cancer patients. On average, those with the defective BRCA2 gene lived an average of four years after diagnosis. The average survival time for prostate cancer patients is 12 years.

WEDNESDAY, June 11 (HealthDay News) -- A drug already approved to reduce the risk of breast cancer in high-risk women also seems to cut the risk for other women.

A new analysis finds that those who took raloxifene (Evista) regularly over a number of years were less likely to develop invasive estrogen-receptor (ER) positive breast cancer, compared with women who did not take the drug.

Raloxifene did not, however, cut the risk for noninvasive breast cancer or invasive ER-negative cancers.